Evan G. Dick - 22 Oct 2021 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
SVP of R&D
Signature
/s/ Tyler J. Vivian, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
22 Oct 2021
Net transactions value
$0
Form type
4
Filing time
25 Oct 2021, 17:29:56 UTC
Previous filing
17 Dec 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTX Common Stock Conversion of derivative security +26,587 +44% 87,139 22 Oct 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Series Seed Preferred Stock Conversion of derivative security -26,587 -100% 0 22 Oct 2021 Common Stock 26,587 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
F2 Includes 39,659 restricted stock units which fully vest on February 24, 2023.
F3 Fully vested.